By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today announced BGI has become a certified service provider for Agilent's SureSelect XT Target Enrichment System for next-generation sequencing.

Based in Shenzhen, China, BGI becomes the first SureSelect XT CSF in that country, and is certified for all SureSelect XT target enrichment protocols, including human all-exon, SureSelect indexing, DNA capture, RNA capture, kinome RNA, and custom kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.